| BED | Biologically Effective Dose | |
| CAF | Cancer-Associated Fibroblast | |
| CRC | Colorectal Cancer | |
| DDR | DNA Damage Response | |
| DNA-PK | DNA-Dependent Protein Kinase | |
| DSB | Double-Strand Break | |
| EGFR-TKI | Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor | |
| GARD | Genomic-Adjusted Radiation Dose | |
| GWAS | Genome-Wide Association Studies | |
| HCC | Hepatocellular Carcinoma | |
| HR | Homologous Recombination | |
| IL-6 | Interleukin-6 | |
| LAPC | Locally Advanced Pancreatic Cancer | |
| LQ | Linear-Quadratic model | |
| MMR | Mismatch Repair | |
| NF-κB | Nuclear Factor kappa B | |
| NHEJ | Non-Homologous End-Joining | |
| NSCLC | Non-Small Cell Lung Cancer | |
| PARP | Poly(ADP-ribose) Polymerase | |
| PDAC | Pancreatic Ductal Adenocarcinoma | |
| PSMA | Prostate-Specific Membrane Antigen | |
| RCC | Renal Cell Carcinoma | |
| ROS | Reactive Oxygen Species | |
| SABR | Stereotactic Ablative Radiotherapy | |
| SBRT | Stereotactic Body Radiotherapy | |
| SRS | Stereotactic Radiosurgery | |
| TGF-β | Transforming Growth Factor-beta | |
| TNF-α | Tumor Necrosis Factor-alpha | |
| VEGF | Vascular Endothelial Growth Factor | |
| Genes | ||
| ATM | Ataxia Telangiectasia Mutated | |
| ATR | ATM and Rad3-Related | |
| BRCA1 | Breast Cancer 1 | |
| BRCA2 | Breast Cancer 2 | |
| EGFR | Epidermal Growth Factor Receptor | |
| KEAP1 | Kelch-Like ECH-Associated Protein 1 | |
| KRAS | Kirsten Rat Sarcoma Viral Oncogene Homolog | |
| LKB1 | Liver Kinase B1 | |
| PTEN | Phosphatase and Tensin Homolog | |
| RAD51 | RAD51 Recombinase | |
| SMAD4 | SMAD Family Member 4 | |
| TP53 | Tumor Protein 53 | |
| VHL | Von Hippel–Lindau | |